SEC 13F Intelligence

Hussman Strategic Advisors, Inc. / PTCT

Hussman Strategic Advisors, Inc.’s Ptc Therapeutics Inc Position

Does Hussman Strategic Advisors, Inc. own Ptc Therapeutics Inc (PTCT)? Not currently — the last reported position was 25.2K shares worth $2M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2025
Shares
25.2K
% of Portfolio
+0.46%
Quarters Held
7
position exited

Position History PTCT

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ1 ’19Q4 ’24: $947,940Q4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $2MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202525.2K$2M+0.46%
Q3 202563.0K$4M+0.84%
Q2 202563.0K$3M+0.70%
Q1 202521.0K$1M+0.26%
Q4 202421.0K$947,940+0.28%
Q1 201950.0K$2M+0.46%
Q4 201850.0K$2M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hussman Strategic Advisors, Inc.’s full portfolio or all institutional holders of PTCT.